mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.

Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Fungal Biology, published by Elsevier Science Ltd, is a premier journal dedicated to advancing the field of mycology and its interdisciplinary applications. With an ISSN of 1878-6146 and E-ISSN 1878-6162, this journal serves as a vital platform for researchers and professionals interested in the ecological, evolutionary, and genetic aspects of fungi, as well as their implications in infectious diseases and plant sciences. As of 2023, it proudly holds a Q2 ranking in Ecology, Evolution, Behavior and Systematics and Plant Science, and a Q3 ranking in Genetics and Infectious Diseases, highlighting its significant contribution to these domains. The journal boasts an impressive Scopus rank, including a percentile of 83rd in Ecological studies, ensuring that published research reaches a wide audience and impacts ongoing discourse in the field. With open access options, Fungal Biology encourages the dissemination of high-quality research, aimed to foster collaboration and innovation among scholars and practitioners. With its convergence of knowledge from 2010 to 2024, this journal is instrumental for those advancing the understanding of fungal biology and its myriad applications in environmental and health sciences.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

MYCOBIOLOGY is an esteemed open-access journal published by Taylor & Francis Ltd, specializing in the fields of Infectious Diseases, Microbiology, and Plant Science. Since its inception, the journal has provided a platform for innovative research, showcasing a diverse range of studies that delve into the complexities of mycology and its vast implications on health, agriculture, and the environment. With a commendable impact factor and a Q2 ranking in Plant Science as of 2023, MYCOBIOLOGY facilitates the dissemination of vital findings to a global audience of researchers, professionals, and students. In addition to its commitment to high-quality content, MYCOBIOLOGY has embraced open access since 2018, ensuring that the latest advancements in mycological research are readily available to the academic community and the public. By bridging gaps in knowledge and fostering collaboration across disciplines, MYCOBIOLOGY plays a crucial role in advancing our understanding of fungal biology and its myriad applications.

MYCOTAXON is a peer-reviewed journal dedicated to the field of mycology, focusing on the taxonomy, systematics, and ecology of fungi. Published by MYCOTAXON LTD, this journal plays a crucial role in advancing our understanding of fungal biodiversity and its significance within various ecosystems. Although it currently does not offer open access options, its contributions are vital to the scientific community, especially with its established presence since 1989. With an HIndex reflecting its relevance and attracting a dedicated readership, MYCOTAXON is recognized within the Q4 quartile in both Ecology, Evolution, Behavior, and Systematics, and Plant Science categories as of 2023. This places it among a critical cohort of journals that contribute to the understanding of ecological dynamics and plant-fungal interactions. Researchers, professionals, and students can benefit from the insights provided in MYCOTAXON, making it an indispensable resource for anyone involved in the study of fungi.

Journal of Fungi is a premier open-access journal published by MDPI, dedicated to advancing the understanding of fungal biology in its myriad forms. Since its inception in 2015, it has become a vital resource in the fields of ecology, evolution, and plant sciences, attaining notable rankings in Scopus, including Q1 status in Ecology, Evolution, Behavior and Systematics, and Plant Science, with a Q2 ranking in Microbiology (medical). The journal fosters a collaborative platform for researchers, professionals, and students by providing unrestricted access to high-quality, peer-reviewed articles, which encourages the dissemination of innovative findings and methodologies relevant to fungal research. Designed to cater to a global audience, the Journal of Fungi has established its significance in the scientific community, especially from its base in Switzerland, where it continues to contribute to the ongoing discourse in mycology and beyond. With its commitment to open access since its launch and its continuous support for groundbreaking research, the journal plays a crucial role in driving forward the scientific inquiry and ecological awareness in fungal studies.

Medical Mycology Case Reports, published by Elsevier, is a pivotal journal dedicated to advancing the field of mycology through the presentation of case reports that highlight clinical findings, diagnostic challenges, and treatment outcomes associated with fungal infections. With its ISSN 2211-7539 and E-ISSN 2211-7539, this open-access journal has been serving the global community since 2012, allowing unrestricted access to its valuable insights. Situated in the Netherlands, specifically at RADARWEG 29, AMSTERDAM, this journal has gained recognition in areas such as Infectious Diseases (ranked Q3) and Microbiology (ranked Q4) as of 2023. Its commitment to disseminating high-quality research is reflected in its Scopus rankings, which place it at the 51st percentile in Medicine and the 32nd percentile in Immunology and Microbiology. By bridging the gap between clinical cases and academic research, Medical Mycology Case Reports plays a crucial role in enriching the knowledge base of practitioners and researchers alike, ultimately contributing to improved patient management and public health.

MYCOPATHOLOGIA, published by Springer in the Netherlands, stands as a pivotal journal in the fields of mycology, plant science, and veterinary microbiology. With its extensive history dating back to 1938, this journal has consistently contributed to the understanding of fungal pathogens and their impact on both agriculture and animal health. It currently holds impressive rankings in Scopus, including Q1 status in Agronomy and Crop Science, and Q2 rankings in Applied Microbiology and Biotechnology, demonstrating its influence and rigor in the scientific community. Researchers and professionals benefit from its curated, high-quality studies which address critical areas such as plant-pathogen interactions and veterinary mycology. While not open access, MYCOPATHOLOGIA emphasizes comprehensive research output and serves as a vital resource for advancing knowledge and fostering innovation in its disciplines. The journal remains committed to disseminating valuable insights that drive forward both academic inquiry and practical applications in related fields, ensuring its relevance and importance in contemporary research.